The chloromethylketone protease inhibitor AAPF(CMK) also targets ATP-dependent helicases and SAP-domain proteins.
Journal
  Journal of cellular biochemistry.
Citation
  J Cell Biochem. 100(3):716-26
Publication date
  2007 Feb 15
Authors
  Dhamne C
Drubin DA
Duncan K
Tevethia MJ
Clawson GA
Investigators
  Gary A. Clawson
Mary J. Tevethia
MeSH headings
  Adenosine Triphosphate
Amino Acid Chloromethyl Ketones
Antigens, Polyomavirus Transforming
DNA Helicases
Oligopeptides
Protease Inhibitors
MeSH qualifiers
  metabolism
pharmacology
Abstract
  We have been studying a nuclear protease, which appears to be involved in cellular transformation, as well as in infections with high-risk human papillomaviruses (HPVs). This protease has a chymotrypsin-like substrate specificity and the chloromethylketone inhibitor AAPF(CMK) is a potent (and relatively selective) inhibitor of it. Recently, we have observed that AAPF(CMK) has potent effects in some model systems which appear not to be mediated by decreases in the nuclear protease. Here we show that AAPF(CMK) selectively reacts with ATP-dependent helicases as well as a limited spectrum of proteins in other DNA repair/chromatin remodeling nuclear complexes, including for example Cohesin complex components and proteins containing SAP-domains. In vitro, AAPF(CMK) selectively reacts with SV40 large T antigen, and inhibits its helicase activity.